Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for healthcare industry professionals · Friday, July 20, 2018 · 456,054,714 Articles · 3+ Million Readers

New Website Offers Information on Phentermine 37.5MG for Weight Loss

/EINPresswire.com/ Phentermine 37.5 is a prescription appetite suppressant that is used together with diet and exercise to treat obesity.

One of the most prescribed diet pills in America today, Phentermine 37.5 diet pill is used as part of a short-term plan, typically 3-6 months, in conjunction with a low calorie diet and moderate activity, for weight reduction. Phentermine 37.5 is typically used for obese patients who have been unable to lose weight on their own through diet and exercise alone. Phentermine 37.5 is available only with a doctor's prescription.

Currently, in the US there are only two categories of prescription drugs used to treat obesity. They include: Phentermine, which suppresses appetite, and Orlistat (Xenical), which helps prevent dietary fat from being absorbed by the intestine. A lower dose, over-the-counter version, of Orlistat is sold as Alli in drugstrores. Phentermine has gained more popularity than Orlistat because of its ease of use. Orlistat is known to yield some unpleasant side effects such as: oily spotting of undergarments; oily or fatty stools; gas with discharge, an oily discharge; loose stools, or an urgent need to go to the bathroom; an increased number of bowel movements; inability to control bowl movements.

Phentermine-375.net is a website dedicated to providing Phentermine 37.5 information, side effects, interaction, weight loss forums and success stories. For more information visit http://phentermine-375.net/.

Phentermine-375.net is a new information based website that was launched to educate users about Phentermine 37.5MG the most prescribed diet pill in the world.

Media Contact:
Jennifer Hughs
jenniferhughs@gmail.com
http://phentermine-375.net/




Press release courtesy of Online PR Media: http://bit.ly/16ZS0nB
Powered by EIN Presswire